Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $20.62 Million |
|---|---|
| Enterprise Value | $18.62 Million |
| Earnings per Share | $5.53 |
| Beta | 1.47 |
| Outstanding Shares | 20,020,239 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -1.03 |
| Enterprise Value to Revenue | -19.04 |
| Enterprise Value to EBIT | 0.41 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.95 |
| Debt to Equity | 0.57 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Innovation1 Biotech Inc. functions as a drug discovery enterprise, primarily engaged in creating modified botanical Schedule 1 molecules for use within the United States. The firm's pipeline encompasses five entirely synthetic, proprieta...